Mereo BioPharma Group Statistics
Total Valuation
MREO has a market cap or net worth of $357.75 million. The enterprise value is $294.38 million.
| Market Cap | 357.75M |
| Enterprise Value | 294.38M |
Important Dates
The last earnings date was Wednesday, March 26, 2025, before market open.
| Earnings Date | Mar 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MREO has 159.00 million shares outstanding. The number of shares has increased by 12.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 159.00M |
| Shares Change (YoY) | +12.16% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 3.19% |
| Owned by Institutions (%) | 46.04% |
| Float | 105.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.85 |
| P/TBV Ratio | 5.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.40, with a Debt / Equity ratio of 0.11.
| Current Ratio | 5.40 |
| Quick Ratio | 5.24 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.37 |
Financial Efficiency
Return on equity (ROE) is -77.58% and return on invested capital (ROIC) is -46.13%.
| Return on Equity (ROE) | -77.58% |
| Return on Assets (ROA) | -39.99% |
| Return on Invested Capital (ROIC) | -46.13% |
| Return on Capital Employed (ROCE) | -73.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.82% in the last 52 weeks. The beta is 0.98, so MREO's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -31.82% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 3.66 |
| Relative Strength Index (RSI) | 34.69 |
| Average Volume (20 Days) | 1,247,672 |
Short Selling Information
| Short Interest | 6.03M |
| Short Previous Month | 6.36M |
| Short % of Shares Out | 3.98% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -45.72M |
| Pretax Income | n/a |
| Net Income | -43.25M |
| EBITDA | -45.13M |
| EBIT | -45.72M |
| Earnings Per Share (EPS) | -$0.29 |
Balance Sheet
The company has $69.80 million in cash and $6.43 million in debt, giving a net cash position of $63.37 million or $0.40 per share.
| Cash & Cash Equivalents | 69.80M |
| Total Debt | 6.43M |
| Net Cash | 63.37M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 60.97M |
| Book Value Per Share | 0.39 |
| Working Capital | 60.92M |
Cash Flow
| Operating Cash Flow | -32.83M |
| Capital Expenditures | n/a |
| Free Cash Flow | -32.83M |
| FCF Per Share | -$0.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MREO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.16% |
| Shareholder Yield | -12.16% |
| Earnings Yield | -12.09% |
| FCF Yield | -9.18% |
Analyst Forecast
The average price target for MREO is $7.71, which is 242.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.71 |
| Price Target Difference | 242.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |